86
75
Growth Score
1 pts
Heat Score
31 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
724594
Sucraid offers an FDA-approved enzyme replacement therapy for sucrase deficiency, part of CSID.
About the Company
Sucraid provides an FDA-approved oral enzyme replacement therapy for the treatment of genetically determined sucrase deficiency, which is part of Congenital Sucrase-Isomaltase Deficiency (CSID). The product, Sucraid® (sacrosidase) Oral Solution, helps patients manage symptoms associated with sucrose ingestion. The SucraidASSIST™ program offers
education, support, and assistance to improve patient outcomes while on Sucraid therapy.
